Skip to main content
. 2024 Jul 19;16(7):960. doi: 10.3390/pharmaceutics16070960

Figure 14.

Figure 14

The effects of the analyzed compounds on cell viability: (a) HUVEC normal cells for 24 h, (b) HUVEC normal cells for 48 h, (c) SK-MEL-24 tumoral cells for 24 h, and (d) SK-MEL-24 tumoral cells for 48 h.